Research map: Use of SGLT2 Inhibitors in Dystrophin Deficient Cardiomyopathy: A Multi-center Study Using the ACTION Registry

Back to the article

Papers in this map

  1. Empagliflozin in Heart Failure with a Preserved Ejection Fraction · Stefan D. Anker · 2021 · 4865 citations · Cited by this paper
  2. Patent Ductus Arteriosus Stenting: From Innovation to Standard of Care—A Field Coming of Age · 2026 · Related
  3. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary · Paul A. Heidenreich · 2022 · 926 citations · Cited by this paper
  4. Incidence, Genetic Characteristics, and Outcomes of Paediatric Cardiomyopathy in a National Cohort (2003–2025) · 2026 · Related
  5. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial · Subha V. Raman · 2014 · 263 citations · Cited by this paper
  6. Quantification of Single Valve Regurgitation in the Pediatric Population Using 3-Dimensional Echocardiography: Reproducibility and Comparison with Cardiac Magnetic Resonance Imaging · 2026 · Related
  7. Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects · Jason R.B. Dyck · 2022 · 177 citations · Cited by this paper
  8. Holter-Based Heart Rate Variability Distinguishes Adolescent Postural Orthostatic Tachycardia Syndrome from Healthy Controls · 2026 · Related
  9. Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload · Milton Packer · 2021 · 173 citations · Cited by this paper
  10. Medical Travel and Geographic Inequities in Access to Pediatric Congenital Heart Surgery: Evidence from a Nationwide Cohort in South Korea · 2026 · Related
  11. A current approach to heart failure in Duchenne muscular dystrophy · Domenico D’Amario · 2017 · 113 citations · Cited by this paper
  12. Bile Acid Pool Expansion and Hemodynamic Associations of the Secondary-to-Primary Bile Acid Ratio in Adult Fontan Circulation · 2026 · Related
  13. Early Clinical Experience with Dapagliflozin in Children with Heart Failure · David M. Newland · 2022 · 72 citations · Cited by this paper
  14. Pulmonary Artery Diameters in Children, Teenagers and Young Adults Derived from Quiescent Interval Slice Selective (QISS) Magnetic Resonance Angiography · 2026 · Related
  15. Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis · Xin Wang · 2023 · 48 citations · Cited by this paper
  16. Lipid Screening and Dyslipidemia in Children with Congenital Heart Disease · 2026 · Related
  17. Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular Dystrophy · Jonathan H. Soslow · 2023 · 30 citations · Cited by this paper
  18. Geographical and Language-Based Factors Associated with Neurodevelopmental Follow-Up in Children with Congenital Heart Disease · 2026 · Related
  19. Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril · Sophie I. Mavrogeni · 2017 · 22 citations · Cited by this paper
  20. Evaluation of Right Ventricular Size Metrics Measured with Cardiac Magnetic Resonance Imaging in Patients with Pulmonary Regurgitation · 2026 · Related
  21. The International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014) · Claire A. Irving · 2025 · 20 citations · Cited by this paper
  22. Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committee · Paul Esteso · 2025 · 13 citations · Cited by this paper
  23. Use of SGLT2 inhibitors in pediatric heart failure: a multi-center study · Ryan J. Butts · 2025 · 8 citations · Cited by this paper
  24. Is the Impact of Sodium–Glucose Co-Transporter 2 (SGLT2) Inhibitors on Bone Metabolism and Fracture Incidence a Class or Drug Effect? A Narrative Review · George Ι. Lambrou · 2025 · 3 citations · Cited by this paper
  25. The Use of Dapagliflozin in Infants and Children with Heart Failure · Emma C. Dunne · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)